跳至主要内容
临床试验/ISRCTN42850134
ISRCTN42850134终止未知

Pneumonia investigation bundle to guide therapy for hospitalised community acquired pneumonia (PIBCAP study)

HS Lothian0 个研究点目标入组 25 人开始时间: 2019年5月28日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Hospitalised for CAP
  • 2. Uncomplicated CAP confirmed by physician
  • 3. CURB65 score two or more
  • 4. Aged 16 and over

排除标准

  • 1. Immunodeficiency - defined as being on long term (?28 days) oral prednisolone 10mg or more per day or other long-term disease-modifying drug
  • 2. All forms of pulmonary fibrosis including usual interstitial pneumonia, asbestosis, non-specific interstitial pneumonia, hypersensitivity pneumonitis, active sarcoidosis
  • 3. No capacity to consent
  • 4. Active malignancy
  • 5. Solid organ transplant
  • 6. COPD on domiciliary oxygen therapy
  • 7. Palliative treatment only
  • 8. Mechanical ventilation
  • 9. End of life care
  • 10. Previously randomised into this trial
  • 11. Participation in another CTIMP or CIMD interventional study

研究者

发起方
HS Lothian

相似试验

Is it better to treat pneumonia by customising... | 临床试验